Shares of Sareum Holdings plc (LON:SAR – Get Free Report) passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 29.14 ($0.39) and traded as low as GBX 26 ($0.35). Sareum shares last traded at GBX 26.50 ($0.35), with a volume of 233,295 shares.
Sareum Stock Down 1.3 %
The firm has a market capitalization of £28.23 million, a PE ratio of -441.67 and a beta of -1.08. The stock has a 50-day moving average price of GBX 29.27 and a 200 day moving average price of GBX 29.14.
About Sareum
Sareum Holdings plc, a clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases. It develops small molecule therapeutic drugs based on its Sareum Kinase Inhibitor Library drug discovery platform. The company's lead product is SDC-1801, a TYK2/JAK1 inhibitor that is in a Phase 1a clinical trials for the treatment of autoimmune diseases.
Further Reading
- Five stocks we like better than Sareum
- Financial Services Stocks Investing
- Rocket Lab Stock Soars: Should Investors Chase the Rally?
- How to Find Undervalued Stocks
- KB Home Slips After Earnings: What’s Next for Homebuilders?
- Options Trading – Understanding Strike Price
- Micron Stock Soars as AI Demand Fuels Big Q4 Earnings Beat
Receive News & Ratings for Sareum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sareum and related companies with MarketBeat.com's FREE daily email newsletter.